Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corkill

Showing results (301-310 of 305) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 305 results.
Journal of Leukocyte Biology|April 4, 2019
Neutrophil GM-CSF receptor dynamics in acute lung injurySilvia De Alessandris, G John Ferguson, Alison J Dodd, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangementL M Pratt, R P Beckett, C L Bellamy, et al.
The European Respiratory Journal|April 20, 2023
Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosisKaterina Koether, Valérie Besnard, Hilary Sandig, et al.
Scientific Reports|June 17, 2023
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunctionElizabeth England, D Gareth Rees, Ian Christopher Scott, et al.
Nature Communications|September 15, 2015
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammationE Suzanne Cohen, Ian C Scott, Jayesh B Majithiya, et al.
Pageof 31

Showing results (301-310 of 305) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 305 results.
Journal of Leukocyte Biology|April 4, 2019
Neutrophil GM-CSF receptor dynamics in acute lung injurySilvia De Alessandris, G John Ferguson, Alison J Dodd, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangementL M Pratt, R P Beckett, C L Bellamy, et al.
The European Respiratory Journal|April 20, 2023
Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosisKaterina Koether, Valérie Besnard, Hilary Sandig, et al.
Scientific Reports|June 17, 2023
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunctionElizabeth England, D Gareth Rees, Ian Christopher Scott, et al.
Nature Communications|September 15, 2015
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammationE Suzanne Cohen, Ian C Scott, Jayesh B Majithiya, et al.
Pageof 31